It has antipyretic effect; it has brain tissue protective effect; it has anti-liver damage effect.

It has the function of protecting brain tissue and resisting liver damage.

It has antipyretic effect; it has brain tissue protective effect; it has anti-liver damage effect.

It has antipyretic effect; it has brain tissue protective effect; it has anti-liver damage effect.

It has antipyretic effect; it has brain tissue protective effect; it has anti-liver damage effect.

It has antipyretic effect; it has brain tissue protective effect; it has anti-liver damage effect.

It has antipyretic effect; it has brain tissue protective effect; it has anti-liver damage effect.

It has antipyretic effect; it has brain tissue protective effect; it has anti-liver damage effect.

This product is an H2 receptor antagonist. It replaces the imidazole ring of cimetidine with a furan ring. It has a higher selectivity for H2 receptors and can significantly inhibit the basal and nocturnal gastric acid secretion of normal people and ulcer patients, as well as the gastric acid secretion caused by pentagastrin, histamine and meals. Its gastric acid inhibition effect is 5 to 12 times stronger than that of cimetidine. Intravenous injection of this product can reduce gastric acid secretion by 90%; it has a certain inhibitory effect on the secretion of pepsinogen. It has a protective effect on experimental gastric mucosal damage and acute ulcers. It has no effect on the secretion of gastrin and sex hormones.

This product can inhibit platelet aggregation and prevent thrombosis. It can also counteract vascular damage caused by 5-hydroxytryptamine and bradykinin, increase capillary resistance, reduce capillary permeability, and prevent edema caused by increased vascular permeability.

This product is a H2 receptor blocker of the guanyl thiazole class, which has the characteristics of high affinity for H2 receptors, and has a significant inhibitory effect on gastric acid secretion, and has an inhibitory effect on basal secretion and the increase of gastric acid and pepsin caused by various stimuli. This product does not change the gastric emptying rate, does not interfere with pancreatic function, and has no adverse effects on the cardiovascular system and kidney function. This product is different from cimetidine, but it is similar to ranitidine, that is, long-term high-dose treatment does not cause adverse reactions of androgen antagonism such as male breast development, impotence, lack of sexual desire, and female breast pain, galactorrhea, etc. It has no teratogenic, carcinogenic, drug enzyme inhibitory and androgen inhibitory effects.

It has the effects of anti-platelet aggregation, dilating arterioles, improving microcirculation, activating blood circulation and removing blood stasis, and has the effect of disaggregating aggregated platelets